The U.S. Food and Drug Administration (FDA) will hold the “FDA NanoDay Symposium 2022” on October 11, 2022. The symposium will address the following topics:

  • An overview and discussion of the recent “Guidance for Industry: Drug Products, Including Biological Products, that Contain Nanomaterials.” More information on the guidance is available in our April 24, 2022, blog item;
  • A contextualized discussion of the development of the COVID mRNA lipid nanoparticle vaccine products;
  • A nonclinical perspective of developmental challenges of products that contain nanomaterials; and
  • The development of regulatory standards and methods for controlling products that contain nanomaterials.

According to FDA, the intended audience includes: